Acetylation and chromosomal functions

Current Opinion in Cell Biology

Volumn 12, Issue 3, 2000, Pages 326-333

  Cheung, Wang L ^a   Briggs, Scott D ^b   Allis, C David ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR;

ACETYLATION; CELL DIFFERENTIATION; CENTROMERE; DNA METHYLATION; GENE DOSAGE; GENOME IMPRINTING; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION;

EID: 0034020466     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00096-X     Document Type: Review

References (71)

1. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 389:1997;251-260.
2. Wolffe A.P., Hayes J.J. Chromatin disruption and modification. Nucleic Acids Res. 27:1999;711-720.
3. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
4. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626.
5. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
6. Berger S.L. Gene activation by histone and factor acetyltransferases. Curr Opin Cell Biol. 11:1999;336-341.
7. Spencer V.A., Davie J.R. Role of covalent modifications of histones in regulating gene expression. Gene. 240:1999;1-12.
8. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45. This review describes how covalent histone modifications may direct a 'histone code' that is interpreted by chromatin-associated complexes. These complexes recognize distinct sets of histone modifications to mediate downstream chromatin functions.
9. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev. 9:1999;40-48.
10. Cortes M., Wong E., Koipally J., Georgopoulos K. Control of lymphocyte development by the Ikaros gene family. Curr Opin Immunol. 11:1999;167-171. This review summarizes the functions of Ikaros family members in B- and T-cell differentiation. The authors present a model in which Ikaros targets a Mi-2/HDAC complex to inaccessible chromatin.
11. Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E., Winandy S., Viel A., Sawyer A., Ikeda T.et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity. 10:1999;345-355. The first report describing that both Ikaros and Aiolos are associated to Mi-2/HDAC and SWI/SNF complexes in lymphocytes.
12. Kuo M.H., Allis C.D. In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment. Methods. 19:1999;425-433.
13. Kelley C.M., Ikeda T., Koipally J., Avitahl N., Wu L., Georgopoulos K., Morgan B.A. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 8:1998;508-515.
14. Roth D.B., Craig N.L. VDJ recombination: a transposase goes to work. Cell. 94:1998;411-414.
15. Engel I., Murre C. Transcription factors in hematopoiesis. Curr Opin Genet Dev. 9:1999;575-579.
16. Grant P.A., Berger S.L. Histone acetyltransferase complexes. Semin Cell Dev Biol. 10:1999;169-177.
17. Massari M.E., Grant P.A., Pray-Grant M.G., Berger S.L., Workman J.L., Murre C. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell. 4:1999;63-73.
18. Kuo M.H., Zhou J., Jambeck P., Churchill M.E., Allis C.D. Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. 12:1998;627-639.
19. Utley R.T., Ikeda K., Grant P.A., Cote J., Steger D.J., Eberharter A., John S., Workman J.L. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature. 394:1998;498-502.
20. Lassar A.B., Davis R.L., Wright W.E., Kadesch T., Murre C., Voronova A., Baltimore D., Weintraub H. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell. 66:1991;305-315.
21. Sartorelli V., Huang J., Hamamori Y., Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 17:1997;1010-1026.
22. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y., Levrero M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell. 1:1997;35-45.
23. Sparrow D.B., Miska E.A., Langley E., Reynaud-Deonauth S., Kotecha S., Towers N., Spohr G., Kouzarides T., Mohun T.J. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18:1999;5085-5098.
24. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:1999;5099-5107.
25. Collingwood T.N., Urnov F.D., Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol. 23:1999;255-275. A comprehensive review of the role of nuclear receptor coactivators and corepressors in chromatin remodeling and gene regulation.
26. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 84:1996;843-851.
27. Imhof A., Yang X.J., Ogryzko V.V., Nakatani Y., Wolffe A.P., Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr Biol. 7:1997;689-692.
28. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
29. Liu L., Scolnick D.M., Trievel R.C., Zhang H.B., Marmorstein R., Halazonetis T.D., Berger S.L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 19:1999;1202-1209.
30. Boyes J., Byfield P., Nakatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 396:1998;594-598.
31. Hung H.L., Lau J., Kim A.Y., Weiss M.J., Blobel G.A. CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol. 19:1999;3496-3505.
32. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell. 4:1999;725-734. Acetylation of MyoD by PCAF, but not by p300, enhances MyoD DNA-binding ability. This provides an explanation for the earlier observation [22] that PCAF HAT activity, but not p300 HAT activity, is required.
33. Chen H., Lin R.J., Xie W., Wilpitz D., Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98:1999;675-686. This report provides a novel regulatory mechanism in hormonal signaling. It shows that a hormone receptor co-factor ACTR, which is itself an acetylase, is regulated by acetylation. In contrast to p53 and MyoD, acetylated ACTR disrupts the HAT co-activator complex to attenuate transcription.
34. Munshi N., Merika M., Yie J., Senger K., Chen G., Thanos D. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell. 2:1998;457-467.
35. Parekh B.S., Maniatis T. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol Cell. 3:1999;125-129.
36. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 399:1999;491-496. This report produced the first insight into the structure and function of the conserved bromodomain found in many acetyltransferases. Using NMR, the PCAF bromodomain was shown to associate with acetylated lysine residues in H3 and H4 peptides.
37. Winston F., Allis C.D. The bromodomain: a chromatin-targeting module? Nat Struct Biol. 6:1999;601-604.
38. Mahoney D.J., Broach J.R. The HML mating-type cassette of Saccharomyces cerevisiae is regulated by two separate but functionally equivalent silencers. Mol Cell Biol. 9:1989;4621-4630.
39. Sager R., Kitchin R. Selective silencing of eukaryotic DNA. Science. 189:1975;426-433.
40. Hennig W. Heterochromatin. Chromosoma. 108:1999;1-9.
41. Vermaak D., Wolffe A.P. Chromatin and chromosomal controls in development. Dev Genet. 22:1998;1-6.
42. Ekwall K., Olsson T., Turner B.M., Cranston G., Allshire R.C. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell. 91:1997;1021-1032.
43. Brown K.E., Guest S.S., Smale S.T., Hahm K., Merkenschlager M., Fisher A.G. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell. 91:1997;845-854.
44. Stillman B. Initiation of chromosome replication in eukaryotic cells. Harvey Lect. 88:1992;115-140.
45. Dutta A., Bell S.P. Initiation of DNA replication in eukaryotic cells. Annu Rev Cell Dev Biol. 13:1997;293-332.
46. Chesnokov I., Gossen M., Remus D., Botchan M. Assembly of functionally active Drosophila origin recognition complex from recombinant proteins. Genes Dev. 13:1999;1289-1296.
47. Loo S., Rine J. Silencing and heritable domains of gene expression. Annu Rev Cell Dev Biol. 11:1995;519-548.
48. Pak D.T., Pflumm M., Chesnokov I., Huang D.W., Kellum R., Marr J., Romanowski P., Botchan M.R. Association of the origin recognition complex with heterochromatin and HP1 in higher eukaryotes. Cell. 91:1997;311-323.
49. Lu B.Y., Eissenberg J.C. Time out: developmental regulation of heterochromatic silencing in Drosophila. Cell Mol Life Sci. 54:1998;50-59.
50. Iizuka M., Stillman B. Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J Biol Chem. 274:1999;23027-23034.
51. Jacobson S., Pillus L. Modifying chromatin and concepts of cancer. Curr Opin Genet Dev. 9:1999;175-184.
52. Ehrenhofer-Murray A.E., Rivier D.H., Rine J. The role of Sas2, an acetyltransferase homologue of Saccharomyces cerevisiae, in silencing and ORC function. Genetics. 145:1997;923-934.
53. Turner B.M., Birley A.J., Lavender J. Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei. Cell. 69:1992;375-384.
54. Braunstein M., Sobel R.E., Allis C.D., Turner B.M., Broach J.R. Efficient transcriptional silencing in Saccharomyces cerevisiae requires a heterochromatin histone acetylation pattern. Mol Cell Biol. 16:1996;4349-4356.
55. Panning B., Jaenisch R. RNA and the epigenetic regulation of X chromosome inactivation. Cell. 93:1998;305-308.
56. Lucchesi J.C. Dosage compensation in flies and worms: the ups and downs of X-chromosome regulation. Curr Opin Genet Dev. 8:1998;179-184.
57. Hilfiker A., Hilfiker-Kleiner D., Pannuti A., Lucchesi J.C. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16:1997;2054-2060.
58. Smith E.R., Pannuti A., Gu W., Steurnagel A., Cook R.G., Allis C.D., Lucchesi J.C. The drosophila MSL complex acetylates histone H4 at lysine 16, a chromatin modification linked to dosage compensation. Mol Cell Biol. 20:2000;312-318.
59. Johnston C.M., Nesterova T.B., Formstone E.J., Newall A.E., Duthie S.M., Sheardown S.A., Brockdorff N. Developmentally regulated Xist promoter switch mediates initiation of X inactivation. Cell. 94:1998;809-817.
60. O'Neill L.P., Keohane A.M., Lavender J.S., Mccabe V., Heard E., Avner P., Brockdorff N., Turner B.M. A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. EMBO J. 18:1999;2897-2907. Xist is an essential gene required for X-inactivation in mammals. Hyperacetylation of histone H4 facilitates a promoter switching [59] which allows a stable Xist RNA transcript to form.
61. Gilbert S.L., Sharp P.A. Promoter-specific hypoacetylation of X inactivated genes. Proc Natl Acad Sci USA. 96:1999;13825-13830. Hypoacetylation of histone H4 was found at promoters of X-linked genes. In addition, methylation of DNA at these promoters correlated with hypoacetylation of histone H4 suggesting that both are required for transcriptional silencing.
62. Keohane A.M., Barlow A.L., Waters J., Bourn D., Turner B.M. H4 acetylation, XIST RNA and replication timing are coincident and define x;autosome boundaries in two abnormal X chromosomes. Hum Mol Genet. 8:1999;377-383.
63. Ng H.H., Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev. 9:1999;158-163. This review discusses DNA methylation in context of chromatin. These authors discuss current reports on MeCP2, a protein that associates with methylated DNA. MeCP2 can associate with the Sin3/HDAC complex to maintain hypoacetylation and transcriptional repression.
64. Pedone P.V., Pikaart M.J., Cerrato F., Vernucci M., Ungaro P., Bruni C.B., Riccio A. Role of histone acetylation and DNA methylation in the maintenance of the imprinted expression of the H19 and Igf2 genes. FEBS Lett. 458:1999;45-50.
65. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 18:1998;6538-6547.
66. Tilghman S.M., Bartolomei M.S., Webber A.L., Brunkow M.E., Saam J., Leighton P.A., Pfeifer K., Zemel S. Parental imprinting of the H19 and Igf2 genes in the mouse. Cold Spring Harb Symp Quant Biol. 58:1993;287-295.
67. McBurney M.W. Gene silencing in the development of cancer. Exp Cell Res. 248:1999;25-29.
68. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 66:1991;817-822.
69. Chiurazzi P., Pomponi M.G., Pietrobono R., Bakker C.E., Neri G., Oostra B.A. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet. 8:1999;2317-2323.
70. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet. 22:1999;98-101.
71. Davie J.R., Samuel S.K., Spencer V.A., Holth L.T., Chadee D.N., Peltier C.P., Sun J.M., Chen H.Y., Wright J.A. Organization of chromatin in cancer cells: role of signalling pathways. Biochem Cell Biol. 77:1999;265-275.